21-46122464-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001849.4(COL6A2):​c.1573-32C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0813 in 1,612,192 control chromosomes in the GnomAD database, including 6,049 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.057 ( 327 hom., cov: 32)
Exomes 𝑓: 0.084 ( 5722 hom. )

Consequence

COL6A2
NM_001849.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.18

Publications

5 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 21-46122464-C-T is Benign according to our data. Variant chr21-46122464-C-T is described in ClinVar as Benign. ClinVar VariationId is 93912.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0886 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A2NM_001849.4 linkc.1573-32C>T intron_variant Intron 19 of 27 ENST00000300527.9 NP_001840.3 P12110-1A0A384MDP3
COL6A2NM_058174.3 linkc.1573-32C>T intron_variant Intron 19 of 27 NP_478054.2 P12110-2
COL6A2NM_058175.3 linkc.1573-32C>T intron_variant Intron 19 of 27 NP_478055.2 P12110-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkc.1573-32C>T intron_variant Intron 19 of 27 1 NM_001849.4 ENSP00000300527.4 P12110-1
COL6A2ENST00000397763.6 linkc.1573-32C>T intron_variant Intron 19 of 27 5 ENSP00000380870.1 P12110-2
COL6A2ENST00000409416.6 linkc.1573-32C>T intron_variant Intron 18 of 26 5 ENSP00000387115.1 P12110-3
COL6A2ENST00000413758.1 linkc.196-32C>T intron_variant Intron 4 of 10 3 ENSP00000395751.1 H7C0M5

Frequencies

GnomAD3 genomes
AF:
0.0575
AC:
8747
AN:
152066
Hom.:
329
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0171
Gnomad AMI
AF:
0.0681
Gnomad AMR
AF:
0.0449
Gnomad ASJ
AF:
0.0783
Gnomad EAS
AF:
0.0195
Gnomad SAS
AF:
0.0628
Gnomad FIN
AF:
0.0265
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.0905
Gnomad OTH
AF:
0.0675
GnomAD2 exomes
AF:
0.0630
AC:
15735
AN:
249836
AF XY:
0.0660
show subpopulations
Gnomad AFR exome
AF:
0.0180
Gnomad AMR exome
AF:
0.0366
Gnomad ASJ exome
AF:
0.0781
Gnomad EAS exome
AF:
0.0235
Gnomad FIN exome
AF:
0.0258
Gnomad NFE exome
AF:
0.0895
Gnomad OTH exome
AF:
0.0682
GnomAD4 exome
AF:
0.0838
AC:
122394
AN:
1460008
Hom.:
5722
Cov.:
34
AF XY:
0.0834
AC XY:
60552
AN XY:
726292
show subpopulations
African (AFR)
AF:
0.0150
AC:
501
AN:
33470
American (AMR)
AF:
0.0386
AC:
1727
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0804
AC:
2101
AN:
26134
East Asian (EAS)
AF:
0.0214
AC:
849
AN:
39698
South Asian (SAS)
AF:
0.0624
AC:
5383
AN:
86244
European-Finnish (FIN)
AF:
0.0279
AC:
1459
AN:
52242
Middle Eastern (MID)
AF:
0.114
AC:
657
AN:
5762
European-Non Finnish (NFE)
AF:
0.0945
AC:
104982
AN:
1111382
Other (OTH)
AF:
0.0784
AC:
4735
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
5839
11679
17518
23358
29197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3784
7568
11352
15136
18920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0574
AC:
8739
AN:
152184
Hom.:
327
Cov.:
32
AF XY:
0.0540
AC XY:
4015
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.0171
AC:
708
AN:
41512
American (AMR)
AF:
0.0448
AC:
686
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0783
AC:
272
AN:
3472
East Asian (EAS)
AF:
0.0196
AC:
101
AN:
5166
South Asian (SAS)
AF:
0.0627
AC:
302
AN:
4820
European-Finnish (FIN)
AF:
0.0265
AC:
281
AN:
10610
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0905
AC:
6156
AN:
67992
Other (OTH)
AF:
0.0664
AC:
140
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
403
806
1209
1612
2015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0738
Hom.:
108
Bravo
AF:
0.0576
Asia WGS
AF:
0.0460
AC:
162
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 16, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
6.8
DANN
Benign
0.73
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17272651; hg19: chr21-47542378; COSMIC: COSV107363117; COSMIC: COSV107363117; API